Harmony Biosciences Holdings Forecast, price target & analysts
Harmony Biosciences Holdings Target price 2026 - Analyst rating & recommendation
Harmony Biosciences Holdings Classifications & Recommendation
Harmony Biosciences Holdings Price Target
| Target Price | $51.00 |
| Price | $41.26 |
| Potential |
23.61%
register free of charge
|
| Number of Estimates | 13 |
|
13 Analysts have issued a price target Harmony Biosciences Holdings 2027 .
The average Harmony Biosciences Holdings target price is $51.00.
This is
23.61%
register free of charge
$73.50
78.14%
register free of charge
$30.30
26.56%
register free of charge
|
|
| A rating was issued by 17 analysts: 12 Analysts recommend Harmony Biosciences Holdings to buy, 4 to hold and 1 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Harmony Biosciences Holdings stock has an average upside potential 2027 of
23.61%
register free of charge
|
Sales and Margin forecast 2026, 2027 to 2033
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Revenue Million $ | 868.45 | 1,052.00 |
| 21.51% | 21.14% | |
| EBITDA Margin | 26.75% | 30.56% |
| 10.94% | 14.24% | |
| Net Margin | 18.27% | 23.03% |
| 10.23% | 26.03% |
13 Analysts have issued a sales forecast Harmony Biosciences Holdings 2026 . The average Harmony Biosciences Holdings sales estimate is
This results in the following potential growth metrics:
7 Analysts have issued an Harmony Biosciences Holdings EBITDA forecast 2026. The average Harmony Biosciences Holdings EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
13 Harmony Biosciences Holdings Analysts have issued a net profit forecast 2026. The average Harmony Biosciences Holdings net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 to 2033
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Earnings Per Share $ | 2.71 | 4.17 |
| 7.97% | 53.87% | |
| P/E | 9.87 | |
| EV/Sales | 1.79 |
13 Analysts have issued a Harmony Biosciences Holdings forecast for earnings per share. The average Harmony Biosciences Holdings EPS is
This results in the following potential growth metrics and future valuations:
Harmony Biosciences Holdings...
Current Harmony Biosciences Holdings Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| Wolfe Research |
Locked
➜
Locked
|
Locked | Aug 26 2026 |
| Truist Securities |
Locked
➜
Locked
|
Locked | Aug 05 2026 |
| Needham |
Locked
➜
Locked
|
Locked | Aug 04 2026 |
| Mizuho |
Locked
➜
Locked
|
Locked | Jul 31 2026 |
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Jul 16 2026 |
| Deutsche Bank |
Locked
➜
Locked
|
Locked | Jun 30 2026 |
| Truist Securities |
Locked
➜
Locked
|
Locked | May 08 2026 |
| Analyst Rating | Date |
|---|---|
|
Locked
Wolfe Research:
Locked
➜
Locked
|
Aug 26 2026 |
|
Locked
Truist Securities:
Locked
➜
Locked
|
Aug 05 2026 |
|
Locked
Needham:
Locked
➜
Locked
|
Aug 04 2026 |
|
Locked
Mizuho:
Locked
➜
Locked
|
Jul 31 2026 |
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Jul 16 2026 |
|
Locked
Deutsche Bank:
Locked
➜
Locked
|
Jun 30 2026 |
|
Locked
Truist Securities:
Locked
➜
Locked
|
May 08 2026 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
